Join The Story Collider and Blueprint Medicines at the Center for Arts at the Armory in Somerville, MA on January 24 for an evening of true, personal stories of exciting innovations in science. This event is FREE but does require registration in advance.
Hosted by Christine Gentry & Katie Wu.
Doors open at 4:30 p.m. Stories start at 5:00 p.m.
Alexis Borisy is a Partner at Third Rock Ventures (TRV), with more than 20 years of experience building and operating innovative science-based organizations. He has played key roles in launching and building several TRV portfolio companies, including Blueprint Medicines, Foundation Medicine, and Relay Therapeutics. Prior to joining Third Rock Ventures, Alexis founded CombinatoRx, serving as its chief executive officer, has raised billions in financing and business development deals, and authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard, Alexis was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year and chosen as New England Entrepreneur of the Year in Life Sciences. He is Vice-Chairman of trustees of Boston’s Museum of Science and serves as Chairman of the National Venture Capital Association. Alexis’ first job was selling peanuts at Wisconsin Badger football games at age 14.
In his role as President and CEO of the Massachusetts Biotechnology Council, Bob Coughlin’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Bob has spent his career in the public and private sectors, including serving as the Undersecretary of Economic Development within Governor Deval Patrick's administration, where he prioritized healthcare and economic development issues and advocated for the state’s life sciences industry. Bob also serves on several non-profit and industry boards, including The Schwartz Center for Compassionate Healthcare. He has received several awards for his contributions, including the first-ever awarded Governor Paul Cellucci Fatherhood Award from the Children’s Trust and the Breath of Life Award from the Cystic Fibrosis Foundation. He graduated from Massachusetts Maritime Academy and served as an officer in the United States Naval Reserve.
Nimita Dave, Ph.D., is a clinical pharmacologist at Blueprint Medicines. Recently relocated from the Midwest, Nimita was born and raised in Mumbai, India, received her B.S. in Pharmaceutical Sciences from the Institute of Chemical Technology in Mumbai, and her Ph.D. in Pharmaceutical Sciences at the University of Cincinnati. Her doctoral dissertation work in glioblastoma received several awards. She then completed a National Institute of Health-sponsored fellowship in Clinical Pharmacology at Indiana University and worked at AbbVie in North Chicago, Ill., before moving to Cambridge this year to join Blueprint. She is also an adjunct faculty at the University of Cincinnati and a mentor with Big Brothers and Big Sisters of America. Nimita, who lives in Cambridge with her husband, Nirmal, and her dog, Hobbes, is passionate about research in rare cancers and dreams of someday seeing a cure for glioblastoma.
Vic Kadambi, Ph.D., leads Nonclinical Development at Blueprint Medicines. An experienced leader in the pharmaceutical field, he has been involved in numerous projects, including first-in-class investigational new drug applications across several therapeutic areas as well as the registration of ADCETRIS and ENTYVIO. Vic earned his B.S. and M.S. in Microbiology from the University of Bombay and his Ph.D. in Cardiovascular Pharmacology and Physiology from the University of Cincinnati. He received the American Heart Association Fellowship, Ohio affiliate, and Young Investigator Award from the Heart Failure Society of America and served as Program Chair for pharmacology- and toxicology-related symposia. Vic is past Chair of the DruSafe part of the International Consortium for Innovation and Quality in Pharmaceutical Development and co-founder of the Boston Area Pharmacology/Toxicology Group. He has over thirty publications and book chapters and has presented posters and oral talks nationally and internationally.
Michael Martelli leads Regulatory Operations at Blueprint Medicines. Born and raised in Cambridge, Mass., Michael is a city boy at heart. He currently lives north of the city with his wife, daughter, son, cat, dog and enjoys the privacy of the suburbs. Michael has more than 15 years of extensive regulatory operations experience in a variety of companies, including Genzyme, Biogen, EMD Serono, and Seres Therapeutics, and enjoys transforming his industry experience into learnings. He has developed original lecture and course material for Salem State University and Northeastern University for Clinical and Regulatory graduate certificates and degree programs. Michael is a natural trainer, facilitator, educator and counsellor. He is warm and gracious and believes in a philosophy of “live and let live.”